(PharmaNewsWire.Com, March 12, 2018 ) The demand for the Diabetic shoes is on a continuous rise in the European region. In last few years, U.K. has recorded a significant increase in the prevalence of diabetes in the country. The number of diabetic population of the U.K. in 2013 was about 3 million with most of the countries like England and Scotland having significant percentage of diabetes prevalence.
With an average prevalence rate of 6% in all the areas, it is anticipated that in future more people would get affected from diabetes in the U.K. and the total diabetic population of the country would expand to 5.1 million by 2025.
U.K. is also witnessing a massive spurt in the total number of obese or overweight population over the past few years. Currently, around 68% of male population and 58% of female population of the state are suffering from obesity problems. It is anticipated that the obesity level would further increase in the state with 75% of males and 65% of females' becoming obese by 2030.
Germany has the lion's share of healthcare spending among all European countries which accounts for 10.5% of its GDP. Around 26% of this spending is contributed on the improvement of diabetic treatment facilities in the country and with rising new cases of diabetes this spending is further expected to increase in future. Thus, citing the above mentioned factors it could be anticipated that the diabetic footwear market of Germany would have more opportunities to flourish during the covered forecast period of 2015-2021.
The report studies the demand and opportunities on the basis of inpatient and outpatient in the region which further has been granule to the country data. In addition to that, to understand the most profitable distribution mode in the region, the market for U.K., Germany, France, Italy, Spain, Hungary, Benelux has been studied based on the online & offline channels. Offline distribution channels further have been studied into specialty store, clinics & street stores.
Key Answers Captured in Report? - Which geography would have better demand for product/services? - What are the strategies adopted by big players in the regional market? - Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth? - What is the current & expected market size in next five years? - What is the market feasibility for long term investment? - What opportunity the country would offer for existing and new players in the market? - What is risk involved for suppliers in the geography? - What factors would drive the demand for the product/service in near future? - What is the impact analysis of various factors in the market growth? - What are the recent trends in the regional market and how successful they are? Table of Contents: 1. List of Figures & Tables 2. Executive Summary 3. Market Entry & Winning Strategy 4. Research Methodology 5. Global Diabetic Footwear Market Size and Forecast 6. Market Segmentation 6.1 By Region 6.1.1 Europe Market Size & Y-O-Y % growth, 2015-2021 6.1.1.1 U.K. Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.1.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.2 Germany Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.2.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.3 France Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.3 Spain Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.3 Italy Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.3 Hungarye Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.1.3 Benelux Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.1 By Demography Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.2 By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6..1.1.3.3 By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 6.1.2 Y-O-Y % Growth Comparison by Country 6.1.3 Europe Base Point Scale (BPS) Analysis- By Demography 6.1.3 Europe Base Point Scale (BPS) Analysis- By Inpatient & Outpatient 6.1.3 Europe Base Point Scale (BPS) Analysis- By Retail Distribution 6.1.4 Europe Market Attractiveness-By Country 6.1.4 Europe Market Attractiveness-By Distribution Channel 6.2 Europe Segmentation By Demography Market Size & Y-O-Y % growth, 2015-2021 6.3 Europe By Inpatient and Outpatient Market Size & Y-O-Y % growth, 2015-2021 6.4 Europe By Retail Distribution Market Size & Y-O-Y % growth, 2015-2021 7. Porter's Five Force Model Analysis 9. Industry Growth Drivers 8.1 Rise in prevalence of diabetes in Europe 8.1.1 Impact Analysis 8.2 Growth in the aging population 8.2.1 Impact Analysis 8.3 Increasing demand of customized diabetic footwear 8.3.1 Impact Analysis 8.4 Rise in spending on diabetes treatment 8.4.1 Impact Analysis 9. Restraints 9.1 High cost of diabetic footwea 9.1.1 Impact Analysis 9.2 Lack of awareness 9.2.1 Impact Analysis 10. Risk Analysis 10.1 Supply Risk 10.2 Demand Risk 11. Competitive Landscape 11.1 DARCO International Inc. 11.1.1 Company Overview 11.1.2 Products and Services 11.1.3 Key Financials 11.1.4 Recent News and Developments 11.2 Sigvaris 11.2.1 Company Overview 11.2.2 Products and services 11.2.3 Key Financials 11.2.4 Recent News and Developments 11.3 Ortho Europe 11.3.1 Company Overview 11.3.2 Products and Services 11.3.3 Key Financials 11.3.4 Recent news and developments 11.4 Duna Srl 11.4.1 Company Overview 11.4.2 Products and services 11.4.3 Key Financials 11.4.4 Recent News & Developments 11.5 Thuasne 11.5.1 Company Overview 11.5.2 Products and Services 11.5.3 Key Financials 11.5.4 Recent news & developments 11.6 Medline Industries 11.6.1 Company Overview 11.6.2 Products and services 11.6.3 Key Financials 11.6.4 Recent news & developments 11.7 DJO Global Inc 11.7.1 Company Overview 11.7.2 Products and services 11.7.3 Key Financials 11.7.4 Recent news & developments 11.8 Hong Kong Grace Shoes Development Co Ltd. 11.8.1 Company Overview 11.8.2 Products and services 11.8.3 Key Financials 11.8.4 Recent news & developments 11.9 Dr. Zen Inc 11.9.1 Company Overview 11.9.2 Products and services 11.9. 3 Key Financials 11.9.4 Recent news & developments 11.10 Supad 11.10.1 Company Overview 11.10.2 Products and services 11.10.3 Key Financials 11.10.4 Recent news & developments 11.11 Drew Shoe Corporation USA 11.11.1 Company Overview 11.11.2 Products and Services 11.11.3 Key Financials 11.11.4 Recent news & developments 11.12 Podartis Srl 11.12.1 Company Overview 11.12.2 Products and Services 11.12.3 Key Financials 11.12.4 Recent news & developments 11.13 Aetrex Worldwide, Inc. 11.13.1 Company overview 11.13.2 Products and Services 11.13.3 Key Financials 11.13.4 Recent news & developments Disclaimer
List of Tables Table 5- 1: Ranking of countries in terms of adult (age 20-79 years) diabetic population (in millions) in 2015 and 2040 Table 5- 2: Ranking of countries in terms of diabetes related health expenditure (USD Billions) in 2015 and 2040
Table 6- 1: Diabetes prevalence % in major countries of U.K. (2012-13) 22
Table 11- 1: DJO Global key financials (USD Millions), 2012-2014 Table 11- 2: DJO Global net sales by products (USD Millions), 2012-2014 Table 11- 3: DJO Global net sales by country (USD Millions), 2012-2014 List of Figures Figure 5- 1: Global Diabetic footwear market size (USD Millions) and Y-O-Y growth (%) Figure 5- 2: Total number of diabetic patients (age 20-79 years) in the world
Figure 6- 1: The U.S. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%) Figure 6- 2: Number of diabetic population (in millions) in the U.S., 2010-2014 Figure 6- 3: Major causes of amputations in U.S. Figure 6- 4: Canada Diabetic footwear market size (USD Millions) and Y-O-Y growth (%) Figure 6- 5: Total number of diabetic patients in Canada (age > 12) Figure 6- 6: Total health expenditure (USD Millions) in Canada during 2010-2014
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
